| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. | Cancer Immun | 2007 | 1.19 |
| 2 | Concurrent decrease in IL-10 with development of immune-related adverse events in a patient treated with anti-CTLA-4 therapy. | Cancer Immun | 2008 | 0.93 |
| 3 | CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. | Cancer Immunol Res | 2013 | 0.82 |